SCHEMBL5556385

SCHEMBL5556385

CSc1nc(NC(N)=O)c(C(=O)O)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
RAB9A P51151 8/20 0.41
MAPT P10636 6/20 0.41
NPC1 O15118 6/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
USP2 O75604 2/20 0.41
HTT P42858 2/20 0.41
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
ALDH1A1 P00352 7/20 0.36
KDM4E B2RXH2 5/20 0.36
HPGD P15428 4/20 0.36
HCRTR1 O43613 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1192351 0.84 LMNA (0.46) LMNARAB9AMAPTNPC1SMN1; SMN2
SCHEMBL6015247 0.81 KDM4E (0.48) LMNARAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL25392748 0.79 LMNA (0.66) LMNARAB9AMAPTNPC1MEN1
SCHEMBL28330333 0.79 LMNA (0.43) LMNARAB9AMAPTNPC1SMN1; SMN2
SCHEMBL1158327 0.75 LMNA (0.61) LMNARAB9AMAPTNPC1SMN1; SMN2
SCHEMBL5551097 0.72 CA1 (0.33) SMN1; SMN2MEN1KMT2AALDH1A1HPGD
SCHEMBL5554779 0.71 ALDH1A1 (0.31) ALDH1A1HPGDTSHR
SCHEMBL3967499 0.69 MAPT (0.47) LMNARAB9AMAPTNPC1SMN1; SMN2
SCHEMBL20489652 0.69 TRPM8 (0.39) LMNARAB9AMAPTNPC1SMN1; SMN2
SCHEMBL164314 0.68 LMNA (0.61) LMNARAB9AMAPTNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070010556-A1 Thiophene derivatives as chk 1 inhibitors ASTRAZENECA AB (SE) 2007-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010556-A1 Thiophene derivatives as chk 1 inhibitors CHEK1, CHKA, CHEK2 LMNA 4241/4885RAB9A 2722/4885MAPT 3514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.